Moderna (MRNA) and CytomX (CTMX) Enter Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
Go back to Moderna (MRNA) and CytomX (CTMX) Enter Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.62 -0.09 (2.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.71 | 52 Week High | $24.68 | |||
| Open | $3.61 | 52 Week Low | $9.10 | |||
| Day High | $3.66 | P/E | N/A | |||
| Day Low | $3.58 | EPS | $0.00 | |||
| Volume | 304,158 | |||||
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 145.64 +0.09 (0.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.55 | 52 Week High | $0.52 | |||
| Open | $145.98 | 52 Week Low | $0.08 | |||
| Day High | $146.00 | P/E | N/A | |||
| Day Low | $140.50 | EPS | $-3.80 | |||
| Volume | 3,339,762 | |||||
